New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - zuclopenthixol hydrochloride 11.82mg equivalent to 10 mg zuclopenthixol - tablet - 10 mg - active: zuclopenthixol hydrochloride 11.82mg equivalent to 10 mg zuclopenthixol excipient: copovidone ethanol glycerol hydrogenated castor oil hypromellose as part of opadry red 02f250002 iron oxide red as part of opadry red 02f250002 lactose monohydrate macrogol 6000 as part of opadry red 02f250002 magnesium stearate microcrystalline cellulose potato starch purified talc titanium dioxide as part of opadry red 02f250002 - acute and chronic schizophrenia and other psychoses, especially those with symptoms such as hallucinations, delusions, thought disturbances, agitation, restlessness, hostility or aggressiveness. manic phase of manic depressive illness. mental retardation associated with psychomotor hyperactivity, agitation, violence and other behavioural disturbances. senile dementia with significant paranoid ideas, confusion, disorientation or behavioural disturbances.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lundbeck sa-nv - zuclopenthixol dihydrochloride 11,82 mg - eq. zuclopenthixol 10 mg - film-coated tablet - 10 mg - zuclopenthixol dihydrochloride 11.82 mg - zuclopenthixol

Israel - English - Ministry of Health

lundbeck israel ltd. - zuclopenthixol as dihydrochloride - film coated tablets - zuclopenthixol as dihydrochloride 10 mg - zuclopenthixol - zuclopenthixol - acute schizophrenia .other acute psychoses.

Israel - English - Ministry of Health

lundbeck israel ltd. - zuclopenthixol as dihydrochloride - film coated tablets - zuclopenthixol as dihydrochloride 2 mg - zuclopenthixol - zuclopenthixol - acute schizophrenia, other acute psycoses.

Israel - English - Ministry of Health

lundbeck israel ltd. - zuclopenthixol as dihydrochloride - film coated tablets - zuclopenthixol as dihydrochloride 25 mg - zuclopenthixol - zuclopenthixol - acute schizophrenia. other acute psychoses.

Australia - English - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - zuclopenthixol hydrochloride, quantity: 11.8 mg (equivalent: zuclopenthixol, qty 10 mg) - tablet, film coated - excipient ingredients: copovidone; purified talc; microcrystalline cellulose; lactose monohydrate; glycerol; potato starch; magnesium stearate; hydrogenated castor oil; titanium dioxide; hypromellose; macrogol 6000; iron oxide red - safety related notification and ammended text of the product information approved as described in the letter dated 28 may 2008 from ceu1. (sub#2008-1319-1) clopixol tablets: acute and chronic schizophrenia and other psychoses, especially those with symptoms such as hallucinations, delusions, thought disturbances, agitation, restlessness, hostility or aggressiveness. manic phase of manic depressive illness.

Ireland - English - HPRA (Health Products Regulatory Authority)

lundbeck ( ireland ) limited - zuclopenthixol hydrochloride - film-coated tablet - 10 milligram(s) - thioxanthene derivatives; zuclopenthixol

Ireland - English - HPRA (Health Products Regulatory Authority)

lundbeck limited - zuclopenthixol dihydrochloride - film coated tablet - 10 milligram - zuclopenthixol

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - zuclopenthixol hydrochloride 25mg - tablet - 25 mg - active: zuclopenthixol hydrochloride 25mg

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - zuclopenthixol hydrochloride 2mg - tablet - 2 mg - active: zuclopenthixol hydrochloride 2mg excipient: lactose monohydrate